NCT00757744View on ClinicalTrials.gov

Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China

PHASE3CompletedINTERVENTIONAL
Enrollment

45

Participants

Timeline

Start Date

September 30, 2007

Primary Completion Date

January 31, 2010

Study Completion Date

September 30, 2010

Conditions
Opiate DependenceHIV Infections
Interventions
BEHAVIORAL

Behavioral Drug and HIV Risk Reduction Counseling (BDRC)

once weekly individual counseling

BEHAVIORAL

Drug counseling

individual drug counseling

Trial Locations (2)

06520

Yale University School of Medicine - CMHC, New Haven

Unknown

Wuhan Center for Disease Control and Prevention, Wuhan

All Listed Sponsors
collaborator

National Institute on Drug Abuse (NIDA)

NIH

lead

Yale University

OTHER

NCT00757744 - Behavioral Drug and HIV Risk Reduction Counseling in Methadone Patients in China | Biotech Hunter | Biotech Hunter